Omics era in type 2 diabetes: From childhood to adulthood

Area of Science:

• Biochemistry
• Genomics
• Pediatrics

Background:

• Pediatric obesity is rising, paralleled by increased type 2 diabetes (T2D) prevalence in children.
• Insulin resistance (IR) is a key factor linking childhood obesity and T2D, contributing to cardiometabolic risks.
• The molecular mechanisms underlying T2D pathophysiology require further elucidation for improved therapeutic options.

Purpose of the Study:

• To summarize recent evidence on omics approaches in type 2 diabetes (T2D) research.
• To highlight the potential of omics data in understanding T2D pathophysiology in both adults and children.
• To explore innovative therapeutic strategies derived from omics findings.

Main Methods:

• Review of recent scientific literature focusing on omics approaches (lipidomics, metabolomics, proteomics, metagenomics) in T2D.
• Analysis of studies investigating the role of specific lipids, such as ceramides, and metabolites in T2D.
• Synthesis of data linking metabolomics pathways to T2D risk and biomarkers.

Main Results:

• Omics approaches are identifying distinct lipids and metabolites as potential therapeutic tools for T2D.
• Ceramides have emerged as a lipid class with a significant pathogenic role in T2D.
• Specific metabolomics pathways are associated with increased T2D risk, offering potential biomarkers.

Conclusions:

• Omics data are crucial for expanding the understanding of T2D pathophysiology.
• Targeting ceramides and utilizing metabolomics pathways present innovative therapeutic strategies for T2D.
• Further research into omics approaches can lead to improved treatments for T2D in pediatric and adult populations.